Multiple sclerosis (MS) is a lifelong disease that causes growing disability and significant challenges for patients, carers, and health systems. Every five minutes, someone is diagnosed, and three million people live with MS worldwide. MS frequently affects people at the height of their working and family-building years. Our research captures this multi-faceted burden of disability through economic modeling and a new survey of neurologists, assessing how MS is measured and managed across seven countries to expose gaps and spotlight best practices.
Whitepaper
Explore the survey results capturing neurologists’ views and experiences with measuring and managing MS-related disability, and our analysis of the economic impact of MS-related disability across France, Germany, Italy, Spain, Sweden, the UK and the US.
Country analysis
United States
75% of neurologists in the US report that a more comprehensive approach is needed to measure disability for people living with MS.
Germany
54% of neurologists in Germany report concerns about the ability of existing measurement tools to detect disability progression.
Spain
More than 40% of MS multidisciplinary teams lack access to mental healthcare and occupational therapy.
Italy
Over 95% of people with MS in Italy experience fatigue, but only 35% of neurologists assess this symptom.
France
Over 80% of MS multidisciplinary teams in France do not provide access to sexual and reproductive healthcare.
Sweden
54% of neurologists in Sweden report concerns about a lack of staff/resources to support comprehensive assessments of disability.
United Kingdom
66% of neurologists in the UK report that there is insufficient time during appointments to administer standardised measures of disability.

